SCINAI IMMUNOTHERAPEUTICS LTD. Rightofuse Assets Increase Decrease In Revaluation Surplus
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Rightofuse Assets Increase Decrease In Revaluation Surplus of ILS 107.00 thousand for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Notes
ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. rightofuse assets increase decrease in revaluation surplus for the quarter ending 2022-06-30 was 107.00K ILS.
ILS
| Period end | Rightofuse Assets Increase Decrease In Revaluation Surplus 3 month | Rightofuse Assets Increase Decrease In Revaluation Surplus 6 month | Rightofuse Assets Increase Decrease In Revaluation Surplus 12 month |
|---|---|---|---|
| 2022-06-30 | 107.00K ILS 6-K/A · filed 2022-08-29 | 107.00K ILS 6-K/A · filed 2022-08-29 | |
| 2021-12-31 | 249.00K ILS 6-K/A · filed 2022-08-29 |
USD
| Period end | Rightofuse Assets Increase Decrease In Revaluation Surplus 6 month | Rightofuse Assets Increase Decrease In Revaluation Surplus 12 month |
|---|---|---|
| 2022-06-30 | $31.00K 6-K/A · filed 2022-08-29 | |
| 2021-12-31 | $80.00K 20-F · filed 2022-03-28 |